Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Ping Huang

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 27, 2017
The percentage of resected and ischemic volume determined by a geometric model is a significant predictor of renal functional change after partial nephrectomyWei-Hsuan Huang, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
Percutaneous Nephrolithotomy Combined Antegrade Flexible Ureteroscope for Complete Staghorn Stones: A Case Report of a New Concept of Stone SurgerySzu-Ying Pan, Chi-Ping Huang, Wen-Chi Chen, et al.
Cell Death & Disease|September 26, 2020
The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancerBianjiang Liu, Yin Sun, Min Tang, et al.
Cell Death & Disease|September 21, 2021
Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progressionMeng Zhang, Yin Sun, Chi-Ping Huang, et al.
Cell Death & Disease|August 29, 2022
High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signalsMin Tang, Yin Sun, Chi-Ping Huang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2022
Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in TaiwanShi-Chen Ou, Sheng-Teng Huang, Mei-Chen Lin, et al.
American Journal of Cancer Research|May 18, 2016
Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial cell carcinoma cellsChi-Cheng Chen, Teng-Fu Hsieh, Chi-Ping Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2019
ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signalsChi-Ping Huang, Jinbo Chen, Chi-Cheng Chen, et al.
American Journal of Cancer Research|October 12, 2016
Androgen receptor facilitates the recruitment of macrophages in tumor microenvironment to promote upper urinary tract urothelial cell carcinoma progressionChi-Cheng Chen, Chi-Ping Huang, Teng-Fu Hsieh, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case ReportYing-Chieh Chang, Szu-Ju Chen, Wei-Hsuan Huang, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 27, 2017
The percentage of resected and ischemic volume determined by a geometric model is a significant predictor of renal functional change after partial nephrectomyWei-Hsuan Huang, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
Percutaneous Nephrolithotomy Combined Antegrade Flexible Ureteroscope for Complete Staghorn Stones: A Case Report of a New Concept of Stone SurgerySzu-Ying Pan, Chi-Ping Huang, Wen-Chi Chen, et al.
Cell Death & Disease|September 26, 2020
The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancerBianjiang Liu, Yin Sun, Min Tang, et al.
Cell Death & Disease|September 21, 2021
Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progressionMeng Zhang, Yin Sun, Chi-Ping Huang, et al.
Cell Death & Disease|August 29, 2022
High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signalsMin Tang, Yin Sun, Chi-Ping Huang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 29, 2022
Effects of Chinese herbal medicine in patients with benign prostatic hyperplasia: A nationwide cohort study in TaiwanShi-Chen Ou, Sheng-Teng Huang, Mei-Chen Lin, et al.
American Journal of Cancer Research|May 18, 2016
Androgen receptor expands the population of cancer stem cells in upper urinary tract urothelial cell carcinoma cellsChi-Cheng Chen, Teng-Fu Hsieh, Chi-Ping Huang, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 26, 2019
ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signalsChi-Ping Huang, Jinbo Chen, Chi-Cheng Chen, et al.
American Journal of Cancer Research|October 12, 2016
Androgen receptor facilitates the recruitment of macrophages in tumor microenvironment to promote upper urinary tract urothelial cell carcinoma progressionChi-Cheng Chen, Chi-Ping Huang, Teng-Fu Hsieh, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Prostate Cancer after Percutaneous Arterial Embolization of the Prostate: A Case ReportYing-Chieh Chang, Szu-Ju Chen, Wei-Hsuan Huang, et al.
Pageof 10